Value of Australia's BreastScreen programme confirmed
This article was originally published in Clinica
The number of women in Australia being diagnosed with breast cancer is rising, according to a new report by the Australian Institute of Health and Welfare. However, according to BreastScreen Australia Monitoring Report 2003-2004, early detection and improved treatments have led to a 26% decrease in the mortality rate from breast cancer for women aged 50-69 (the age group for which free screening is provided every two years). In the 14 years to 2004, the death rate dropped by 2.1% per year, to 50.9 per 100,000 in 2004, whereas it stood at 68.5 per 100,000 in 1990. The incidence of invasive breast cancers in the target age group is high. In 2004, 3,851 invasive breast cancers were detected across all groups, of which 2,733 were found in women in the target age group.
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.